# clm_BC2C8A20F65B

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: revenue  
value: 238,457,000 United States dollar  
valid_from: 2008-12-31  
valid_to: 2009-12-31  
published: 2011-02-17  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_F4AAD27D2977  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals revenue: 238,457,000 United States dollar", as of 2008-12-31 (until 2009-12-31). Claim clm_BC2C8A20F65B, https://asof.is/claim/clm_BC2C8A20F65B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:Revenues in 10-K FY2010, filed 2011-02-17  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm (primary, SEC EDGAR 10-K FY2010, published 2011-02-17)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.